Aspen Pharmacare (APNHY.PK)
is likely to be a very frustrating stock to many SA readers. While this
company may be one of the best publicly-traded plays on the growth of
the healthcare markets in Africa, Latin America, and Asia, the stock
already sports a very steep multiple. What's more, its ADR shares are
incredibly illiquid in the U.S., and only the Johannesburg-traded shares
(APNJ.J) offer much liquidity. But for investors who can be patient, an
opportunity to acquire shares in this company could be one of those
rare once-in-a-decade opportunities.
Please continue below:
Aspen Pharmacare Offers Very Expensive Developing World Growth
No comments:
Post a Comment